Reduced exacerbations following switch from multiple-inhaler to once-daily single-inhaler triple therapy in COPD patients in a real-world primary care setting in England
K. Rothnie (Brentford, United Kingdom), R. Wood (Bollington, United Kingdom), A. Czira (Brentford, United Kingdom), V. Banks (Bollington, United Kingdom), L. Camidge (Bollington, United Kingdom), O. Massey (Bollington, United Kingdom), M. Seif (Bollington, United Kingdom), C. Compton (Brentford, United Kingdom), R. Sharma (Brentford, United Kingdom), A. Ismaila (Collegeville, United States)
Source: International Congress 2022 – COPD management: comorbidities, cohorts and real-world studies
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Rothnie (Brentford, United Kingdom), R. Wood (Bollington, United Kingdom), A. Czira (Brentford, United Kingdom), V. Banks (Bollington, United Kingdom), L. Camidge (Bollington, United Kingdom), O. Massey (Bollington, United Kingdom), M. Seif (Bollington, United Kingdom), C. Compton (Brentford, United Kingdom), R. Sharma (Brentford, United Kingdom), A. Ismaila (Collegeville, United States). Reduced exacerbations following switch from multiple-inhaler to once-daily single-inhaler triple therapy in COPD patients in a real-world primary care setting in England. 2109
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|